A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Mailman's Y. Claire Wang finds that with 1 in 7 adults severely obese, overall medical costs reached an estimated $69 billion for obesity-related health issues.
A study by Mailman School of Public Health researchers links exposure to famine in the first trimester of pregnancy with the risk of developing diabetes in later life.
A neuroscientist and obesity researcher at the Naomi Berrie Diabetes Center is mapping the regions of the brain that either respond or fail to respond to weight loss.
Researchers have found a cellular defect that can impair the body’s ability to handle high glucose levels, pointing the way to new treatments for diabetes.
Columbia researchers have developed a method to generate hypothalamic-like neurons from human pluripotent stem cells, which could aid the study of obesity.